Клинико-лабораторная характеристика и оценка эффективности терапии хронического миелоидного лейкоза на территории Приморского края

Просекова Елена Викторовна, Климов Владимир Сергеевич, V.A. Sabynych et al. · JOURNAL of SIBERIAN MEDICAL SCIENCES · 2013

The work presents the analysis of incidence and clinical and laboratory assessment of efficiency of imatinib application to chronic myeloid leukosis (CML) therapies at 82 patients in the territory of Primorsky Krai, registered from January 1, 2005 to December 31, 2011. The average value of annual incidence of CML among adult population of Primorsky Krai made 0,85 on 100 000. The general survival of patients made 85,3%, at the patients who were receiving imatinib, — 92,6%. The big cytogenetic answer was reached at 67,6% of the patients, full at — 55,8%.

Cited by 0 works.

Authors